Amaç: Artan antibiyotik direnci, idrar yolu enfeksiyonlarının (İYE) yönetiminde daha yüksek morbidite, mortalite ve maliyetlerle ilişkili önemli bir sorundur. Bu çalışma, ilk kez toplum kökenli İYE geçiren çocuklardan izole edilen üropatojenlerin antimikrobiyal direnç profilini analiz etmeyi amaçlamaktadır.
Gereç ve Yöntemler: Bu retrospektif kohort çalışması, Ocak 2010-Aralık 2016 tarihleri arasında, üçüncü basamak bir çocuk hastanesinin polikliniklerinde ilk toplum kökenli İYE atağı tanısı konan bir ay ile 18 yaş arasındaki hastalarla yapıldı. Hastaların yaşı, cinsiyeti, İYE öyküsü, başvurudaki klinik bulguları, idrar analizi, idrar kültürü ve antibiyogram sonuçları kaydedildi.
Bulgular: Çalışmaya toplam 1086 hasta ve 1086 kültür dahil edildi. Erkek/kadın oranı 1/5.3’dü. Çocukların yaş ortalaması 73.7±47.1 (0.4-215.9) aydı. %16’sı 1-24 aylıktı. E. coli sıklık olarak %85.1 ile en sık etken etkendi. Genel antimikrobiyal direncin ampisilin için en yüksek olduğu, ampisilini piperasilin ve trimetoprim-sülfametoksazolün (sırasıyla %63.5, %41.6 ve %38.1) takip ettiği bulundu. İmipenem, amikasin ve tobramisin en düşük dirence sahipti (sırasıyla %0.5, 0.5 ve %7.6). Amoksisilin-klavulanat, ampisilin-sulbaktam, sefuroksim, seftriakson’a karşı genel antimikrobiyal direnç oranı sırasıyla %19.4, 24, %25.9 ve %21.1’di. Örneklerin %5.6’sında (n=61) geniş spektrumlu beta-laktamaz pozitifliği saptandı.
Sonuç: Çalışmamız, idrar kültürü ve antibiyotik duyarlılık sonuçları belirlenmeden önce reçete edilen en yaygın antibiyotiklere karşı antimikrobiyal dirençte önemli artış olduğunu göstermiştir. Amoksisilin-klavulanat, ampisilin-sulbaktam, sefuroksim, seftriakson için direnç oranları, ayakta tedavi ortamında ilk İYE atağı olan çocuklarda neredeyse %20 veya üzerindedir.
Objective: Increased antibiotic resistance is a significant problem associated with higher morbidity, mortality, and costs in managing urinary tract infections (UTI). This study aims to analyze the antimicrobial resistance profile of uropathogens isolated from children with the first attack of community-acquired UTI.
Material and Methods: This retrospective cohort study was conducted between January 2010-December 2016, with the patients aged one month to 18 years diagnosed with the first attack of community-acquired UTI at the pediatric outpatient clinic of a tertiary care hospital. Patients’ age, sex, UTI history, clinical findings at admission, urine analysis, urine culture, and antibiogram results were recorded.
Results: A total of 1086 patients and 1086 cultures were included in the study. The male/female ratio was 1/5.3. The mean age of the children was 73.7±47.1 (0.4-215.9) months. 16.0% were aged 1-24 months. E. coli was the most common causative agent found to be 85.1% in frequency. The overall antimicrobial resistance was found to be highest for ampicillin, followed by piperacillin and trimethoprim-sulfamethoxazole (63.5, 41.6 and 38.1%, respectively). Imipenem, amikacin, and tobramycin had the least resistance (0.5, 0.5, and 7.6%, respectively). The overall antimicrobial resistance against amoxicillin-clavulanate, ampicillin-sulbactam, cefuroxime, ceftriaxone was 19.4, 24, 25.9 and 21.1%; respectively.Extended-spectrum beta-lactamase positivity was detected in 5.6% (n=61) of samples.
Conclusion: Our study showed significant increase in antimicrobial resistance to the most common antibiotics which are prescribed before urine culture results and antibiotic sensitivities are available. The resistance rates for amoxicillin-clavulanate, ampicillin-sulbactam, cefuroxime, ceftriaxone was almost 20% or above in children with the first UTI attack in an outpatient setting.
Primary Language | English |
---|---|
Subjects | Internal Diseases |
Journal Section | ORIGINAL ARTICLES |
Authors | |
Publication Date | March 16, 2022 |
Submission Date | February 11, 2022 |
Published in Issue | Year 2022 Volume: 16 Issue: 2 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 7 articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.